BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

712 related articles for article (PubMed ID: 33866970)

  • 41. Three-year and five-year outcomes of surgical resection for pancreatic ductal adenocarcinoma: Long-term experiences in one medical center.
    Hsu CP; Hsu JT; Liao CH; Kang SC; Lin BC; Hsu YP; Yeh CN; Yeh TS; Hwang TL
    Asian J Surg; 2018 Mar; 41(2):115-123. PubMed ID: 28010955
    [TBL] [Abstract][Full Text] [Related]  

  • 42. International Study Group of Pancreatic Surgery type 3 and 4 venous resections in patients with pancreatic adenocarcinoma:the Paoli-Calmettes Institute experience.
    Al Faraï A; Garnier J; Ewald J; Marchese U; Gilabert M; Moureau-Zabotto L; Poizat F; Giovannini M; Delpero JR; Turrini O
    Eur J Surg Oncol; 2019 Oct; 45(10):1912-1918. PubMed ID: 31186204
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Radical antegrade modular pancreatosplenectomy (RAMPS) versus conventional distal pancreatosplenectomy (CDPS) for left-sided pancreatic ductal adenocarcinoma.
    Dai M; Zhang H; Li Y; Xing C; Ding C; Liao Q; Zhang T; Guo J; Xu Q; Han X; Liu W; Liu Q
    Surg Today; 2021 Jul; 51(7):1126-1134. PubMed ID: 33389192
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Modified Appleby procedure for borderline resectable/locally advanced distal pancreatic adenocarcinoma: A major procedure for selected patients.
    Cesaretti M; Abdel-Rehim M; Barbier L; Dokmak S; Hammel P; Sauvanet A
    J Visc Surg; 2016 Jun; 153(3):173-81. PubMed ID: 26775202
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Adjuvant surgical therapy for patients with initially-unresectable pancreatic cancer with long-term favorable responses to chemotherapy.
    Kato K; Kondo S; Hirano S; Tanaka E; Shichinohe T; Tsuchikawa T; Matsumoto J
    J Hepatobiliary Pancreat Sci; 2011 Sep; 18(5):712-6. PubMed ID: 21455748
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Predictors for Long-Term Survival After Resection of Pancreatic Ductal Adenocarcinoma: A Systematic Review and Meta-Analysis.
    Javed AA; Mahmud O; Fatimi AS; Habib A; Grewal M; He J; Wolfgang CL; Besselink MG;
    Ann Surg Oncol; 2024 Jul; 31(7):4673-4687. PubMed ID: 38710910
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Portal vein resection in advanced pancreatic adenocarcinoma: is it worth the risk?
    Marsoner K; Langeder R; Csengeri D; Sodeck G; Mischinger HJ; Kornprat P
    Wien Klin Wochenschr; 2016 Aug; 128(15-16):566-72. PubMed ID: 27363995
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Prognostic factors for actual long-term survival in the era of multidisciplinary treatment for pancreatic ductal adenocarcinoma.
    Nakagawa K; Akahori T; Nishiwada S; Nagai M; Nakamura K; Tanaka T; Tamamoto T; Ohbayashi C; Hasegawa M; Kichikawa K; Ikeda N; Sho M
    Langenbecks Arch Surg; 2018 Sep; 403(6):693-700. PubMed ID: 30218193
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Survival benefit of neoadjuvant therapy in patients with non-metastatic pancreatic ductal adenocarcinoma: A propensity matching and intention-to-treat analysis.
    Sugimoto M; Takahashi N; Farnell MB; Smyrk TC; Truty MJ; Nagorney DM; Smoot RL; Chari ST; Carter RE; Kendrick ML
    J Surg Oncol; 2019 Nov; 120(6):976-984. PubMed ID: 31452208
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Laparoscopic Distal Pancreatectomy for Pancreatic Ductal Adenocarcinoma: Time for a Randomized Controlled Trial? Results of an All-inclusive National Observational Study.
    Sulpice L; Farges O; Goutte N; Bendersky N; Dokmak S; Sauvanet A; Delpero JR;
    Ann Surg; 2015 Nov; 262(5):868-73; discussion 873-4. PubMed ID: 26583678
    [TBL] [Abstract][Full Text] [Related]  

  • 51. A new preoperative prognostic scoring system to predict prognosis in patients with locally advanced pancreatic body cancer who undergo distal pancreatectomy with en bloc celiac axis resection: a retrospective cohort study.
    Miura T; Hirano S; Nakamura T; Tanaka E; Shichinohe T; Tsuchikawa T; Kato K; Matsumoto J; Kondo S
    Surgery; 2014 Mar; 155(3):457-67. PubMed ID: 24462074
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Prognosis of malignant intraductal papillary mucinous tumours of the pancreas after surgical resection. Comparison with pancreatic ductal adenocarcinoma.
    Maire F; Hammel P; Terris B; Paye F; Scoazec JY; Cellier C; Barthet M; O'Toole D; Rufat P; Partensky C; Cuillerier E; Lévy P; Belghiti J; Ruszniewski P
    Gut; 2002 Nov; 51(5):717-22. PubMed ID: 12377813
    [TBL] [Abstract][Full Text] [Related]  

  • 53. R1 resection in pancreatic cancer has significant impact on long-term outcome in standardized pathology modified for routine use.
    Rau BM; Moritz K; Schuschan S; Alsfasser G; Prall F; Klar E
    Surgery; 2012 Sep; 152(3 Suppl 1):S103-11. PubMed ID: 22766366
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Laparoscopic resection of exocrine carcinoma in central and distal pancreas results in a high rate of radical resections and long postoperative survival.
    Marangos IP; Buanes T; Røsok BI; Kazaryan AM; Rosseland AR; Grzyb K; Villanger O; Mathisen Ø; Gladhaug IP; Edwin B
    Surgery; 2012 May; 151(5):717-23. PubMed ID: 22284762
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Pancreatic volume is one of the independent prognostic factors for resectable pancreatic ductal adenocarcinomas.
    Fukumoto T; Watanabe T; Hirai I; Kimura W
    J Hepatobiliary Pancreat Sci; 2016 Aug; 23(8):472-9. PubMed ID: 27246905
    [TBL] [Abstract][Full Text] [Related]  

  • 56. A contemporary analysis of survival for resected pancreatic ductal adenocarcinoma.
    Lewis R; Drebin JA; Callery MP; Fraker D; Kent TS; Gates J; Vollmer CM
    HPB (Oxford); 2013 Jan; 15(1):49-60. PubMed ID: 23216779
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Detrimental effect of postoperative complications on oncologic efficacy of R0 pancreatectomy in ductal adenocarcinoma of the pancreas.
    Kang CM; Kim DH; Choi GH; Kim KS; Choi JS; Lee WJ
    J Gastrointest Surg; 2009 May; 13(5):907-14. PubMed ID: 19224295
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Laparoscopic radical 'no-touch' left pancreatosplenectomy for pancreatic ductal adenocarcinoma: technique and results.
    Abu Hilal M; Richardson JR; de Rooij T; Dimovska E; Al-Saati H; Besselink MG
    Surg Endosc; 2016 Sep; 30(9):3830-8. PubMed ID: 26675941
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Survival after resection of pancreatic adenocarcinoma: results from a single institution over three decades.
    Winter JM; Brennan MF; Tang LH; D'Angelica MI; Dematteo RP; Fong Y; Klimstra DS; Jarnagin WR; Allen PJ
    Ann Surg Oncol; 2012 Jan; 19(1):169-75. PubMed ID: 21761104
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Combined hepatic arterial resection in pancreatic resections for locally advanced pancreatic cancer.
    Miyazaki M; Yoshitomi H; Takano S; Shimizu H; Kato A; Yoshidome H; Furukawa K; Takayashiki T; Kuboki S; Suzuki D; Sakai N; Ohtuka M
    Langenbecks Arch Surg; 2017 May; 402(3):447-456. PubMed ID: 28361216
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 36.